Abstract 10129: Long-Term Prescription of Beta-Blockers After Myocardial Infarction with Preserved Left Ventricular Function is Associated with Reduction in Recurrent ACS but Not Repeat Revascularization or All-Cause Mortality

Michael H. Chiu,Yuan Dong,Danielle A. Southern,Nowell M. Fine,McAlister Finlay,Tolulope T. Sajobi,Michelle M. Graham,Sean van Diepen,Matthew T. James,Stephen B. Wilton

Abstract 10129: Long-Term Prescription of Beta-Blockers After Myocardial Infarction with Preserved Left Ventricular Function is Associated with Reduction in Recurrent ACS but Not Repeat Revascularization or All-Cause Mortality

2021

Michael H. Chiu
Yuan Dong
Danielle A. Southern
Nowell M. Fine
McAlister Finlay
Tolulope T. Sajobi
Michelle M. Graham
Sean van Diepen
Matthew T. James
Stephen B. Wilton

Background: Beta-blockers (BB) are cornerstones of medical therapy for acute coronary syndromes (ACS). However, benefits of long-term treatment with preserved left ventricular ejection fraction (LV...

Keywords:

Beta (finance)
Beta blocker
all cause mortality
Myocardial infarction
Cardiology
ventricular function
Internal medicine
Medical prescription
repeat revascularization
Ejection fraction
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations